Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler

The product will be manufactured at subsidiary Aurolife Pharma’s Raleigh facility in North Carolina and expected to be launched in upcoming quarters.
More news in Industry
Sai Parenterals acquiring majority stake in Bion
Mumbai luxury housing market shifts towards larger 4 BHK homes
Wipro 3D ties up with Markforged to expand industrial 3D printing in India
Amazon to invest $7 billion in India renewables by 2030
Rupee rises 43 paise to close at 93.51 (provisional) against U.S. dollar